Metastatic Genitourinary System Carcinoma

1 clinical trials · Condition

Record	Firm	Date
Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes (NCT03375307)	National Cancer Institute (NCI)	2020-11-03

Every clearance here is in the API, with alerts when new ones post.